• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 13th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 13th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
The Role Of Thrombomodulin ™ And Endothelial Protein C Receptor (epcr) In Maternal Placental Hemostasis
Home ‹ 2010 Abstracts ‹ The Role Of Thrombomodulin ™ And Endothelial Protein C Receptor (epcr) In Maternal Placental Hemostasis

Thrombomodulin (TM) and endothelial protein C receptor (EPCR) are members of the protein Canticoagulant pathway, involved in hemostasis and inflammation in the vascular bed. We evaluated the role of TM/EPCR in non-pregnant women (NP), healthy pregnant women (HP), women with gestation vascular complications (GVC) and LMWH-treated pregnant females. TM/EPCR gene expression and antigen levels were examined in patient samples (placental sections and circulating microvesicles [MVs]), human umbilical vein endothelial cells (HUVEC) and trophoblasts, using quantitative PCR, flow cytometry and fluorescent microscopy methods.

HUVEC and trophoblasts expressed high levels of EPCR (~80%) which decreased in their related MVs (25-40%). TM expression on 24-week gestation trophoblasts was ~25% and increased to ~60% in term placental trophoblasts. TM antigen could not be detected on HUVEC or trophoblast MVs. TM gene expression decreased in placentas of the GVC cohort compared to the HP and restored in the LMWH-treated group. Circulating MVs expressed moderate levels of EPCR (~30%) without significant differences between HP, GVC and NP groups. Surprisingly, we failed to find TM in circulating MVs of study cohorts

However, MVs from study groups increased TM and EPCR gene expression and TM antigen levels on HUVEC relative to untreated cells.

MVs of the GVC group reduced EPCR antigen level on trophoblasts compared to untreated cells.

Conclusion: Decrease in TM expression related to pregnancy complications, effect of GVCMVs. 1,2,, Rami Sammour 3, Yaniv Zipori4, Naomi Lanir1,2, Benjamin Brenner1,2, Anat Aharon 1,2.

Author

Einat Shomer

Bruce Rappaport Faculty of Medicine, Technion Haifa, Israel

1. Thrombosis and Hemostasis Unit,Dept. of Hematology, Rambam Health Care Campus, Haifa, Israel

2. Dept. of Obstetrics and Gynecology, Bnai-Zion Medical Center, Haifa, Israel

3. Dept. of Obstetrics and Gynecology4, Rambam Health Care Campus, Haifa, Israel

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top